• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心脏移植患者冠状动脉血运重建术:系统评价和荟萃分析。

Coronary Artery Revascularization in Heart Transplant Patients: A Systematic Review and Meta-Analysis.

机构信息

Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta, Canada.

Division of Cardiac Surgery, Department of Surgery, University of Alberta, Edmonton, Alberta, Canada.

出版信息

Cardiology. 2022;147(3):348-363. doi: 10.1159/000524781. Epub 2022 May 2.

DOI:10.1159/000524781
PMID:35500568
Abstract

BACKGROUND

Cardiac allograft vasculopathy (CAV) is the primary cause of late mortality after heart transplantation. We look to provide a comprehensive review of contemporary revascularization strategies in CAV.

METHODS

PubMed and Web of Science were systematically searched by 3 authors. 1,870 articles were initially screened and 24 were included in this review.

RESULTS

PCI is the main revascularization technique utilized in CAV. The pooled estimates for restenosis significantly favored DES over BMS (OR 4.26; 95% CI: 2.54-7.13; p < 0.00001; I2 = 4%). There were insufficient data to quantitatively compare mortality following DES versus BMS. There was no difference in short-term mortality between CABG and PCI. In-hospital mortality was 0.0% for CABG and ranged from 0.0 to 8.34% for PCI. One-year mortality was 8.0% for CABG and 5.0-25.0% for PCI. CABG had a potential advantage at 5 years. Five-year mortality was 17.0% for CABG and ranged from 14 to 40.4% following PCI. Select measures of postoperative morbidity trended toward superior outcomes for CABG.

CONCLUSION

In CAV, PCI is the primary revascularization strategy utilized, with DES exhibiting superiority to BMS regarding postoperative morbidity. Further investigation into outcomes following CABG in CAV is required to conclusively elucidate the superior management strategy in CAV.

摘要

背景

心脏同种异体移植血管病(CAV)是心脏移植后晚期死亡的主要原因。我们旨在对 CAV 中的当代血运重建策略进行全面回顾。

方法

由 3 位作者对 PubMed 和 Web of Science 进行系统检索。最初筛选出 1870 篇文章,其中 24 篇文章纳入本综述。

结果

PCI 是 CAV 中主要的血运重建技术。DES 组再狭窄的汇总估计明显优于 BMS 组(OR 4.26;95%CI:2.54-7.13;p < 0.00001;I2 = 4%)。没有足够的数据对 DES 与 BMS 后死亡率进行定量比较。DES 与 PCI 的短期死亡率无差异。CABG 的院内死亡率为 0.0%,PCI 的范围为 0.0-8.34%。CABG 的 1 年死亡率为 8.0%,PCI 的 1 年死亡率为 5.0-25.0%。CABG 在 5 年内可能具有优势。CABG 的 5 年死亡率为 17.0%,PCI 的范围为 14-40.4%。术后发病率的某些衡量指标倾向于 CABG 的结果更好。

结论

在 CAV 中,PCI 是主要的血运重建策略,DES 在术后发病率方面优于 BMS。需要进一步研究 CABG 在 CAV 中的结果,以明确 CAV 的最佳管理策略。

相似文献

1
Coronary Artery Revascularization in Heart Transplant Patients: A Systematic Review and Meta-Analysis.心脏移植患者冠状动脉血运重建术:系统评价和荟萃分析。
Cardiology. 2022;147(3):348-363. doi: 10.1159/000524781. Epub 2022 May 2.
2
Percutaneous coronary intervention versus coronary artery bypass grafting in heart transplant recipients with coronary allograft vasculopathy: a systematic review and meta-analysis of 1,520 patients.心脏移植受者发生冠状动脉移植血管病变时,经皮冠状动脉介入治疗与冠状动脉旁路移植术的比较:1520例患者的系统评价和荟萃分析
Ann Cardiothorac Surg. 2018 Jan;7(1):19-30. doi: 10.21037/acs.2018.01.10.
3
Comparison of percutaneous coronary intervention with bare-metal and drug-eluting stents for cardiac allograft vasculopathy.裸金属支架与药物洗脱支架经皮冠状动脉介入治疗心脏移植血管病变的比较。
JACC Cardiovasc Interv. 2008 Dec;1(6):710-5. doi: 10.1016/j.jcin.2008.10.001.
4
CABG Versus PCI: Greater Benefit in Long-Term Outcomes With Multiple Arterial Bypass Grafting.冠状动脉搭桥术与经皮冠状动脉介入治疗:多支动脉搭桥术在长期预后方面具有更大益处。
J Am Coll Cardiol. 2015 Sep 29;66(13):1417-27. doi: 10.1016/j.jacc.2015.07.060.
5
Comparing long-term outcomes between drug-eluting and bare-metal stents in the treatment of cardiac allograft vasculopathy.比较药物洗脱支架与裸金属支架治疗心脏移植血管病变的长期疗效。
Catheter Cardiovasc Interv. 2009 Oct 1;74(4):543-9. doi: 10.1002/ccd.22058.
6
Long-term clinical and angiographic outcomes of percutanenous coronary intervention with everolimus-eluting stents for the treatment of cardiac allograft vasculopathy.依维莫司洗脱支架经皮冠状动脉介入治疗心脏移植血管病变的长期临床和血管造影结果
Catheter Cardiovasc Interv. 2017 Jul;90(1):48-55. doi: 10.1002/ccd.26830. Epub 2016 Nov 10.
7
Five-year outcomes comparing percutaneous coronary intervention with drug-eluting stents versus coronary artery bypass grafting in patients with left main coronary artery disease: A systematic review and meta-analysis.比较左主干冠状动脉疾病患者经皮冠状动脉介入治疗与药物洗脱支架置入与冠状动脉旁路移植术的 5 年结局:系统评价和荟萃分析。
Atherosclerosis. 2020 Sep;308:50-56. doi: 10.1016/j.atherosclerosis.2020.06.024. Epub 2020 Jul 4.
8
Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.药物洗脱支架经皮冠状动脉介入治疗与旁路手术治疗 3 支血管病变或左主干病变患者的成本效益:紫杉醇药物洗脱支架与心脏手术(SYNTAX)试验的最终结果。
Circulation. 2014 Sep 30;130(14):1146-57. doi: 10.1161/CIRCULATIONAHA.114.009985. Epub 2014 Aug 1.
9
Percutaneous coronary artery revascularization procedures in pediatric heart transplant recipients: A large single center experience.小儿心脏移植受者的经皮冠状动脉血运重建术:一项大型单中心经验。
Catheter Cardiovasc Interv. 2016 Nov;88(5):797-803. doi: 10.1002/ccd.26544. Epub 2016 Apr 16.
10
Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization.冠状动脉血运重建术后卒率比较:外科手术与经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2018 Jul 24;72(4):386-398. doi: 10.1016/j.jacc.2018.04.071.

引用本文的文献

1
In the Twilight of Evidence: Is Bypass Surgery Still on the Table for Cardiac Allograft Vasculopathy?在证据的黄昏时刻:心脏移植血管病变的搭桥手术是否仍可行?
J Clin Med. 2024 Dec 29;14(1):132. doi: 10.3390/jcm14010132.
2
SUVmean ratios of liver/muscle and lung/muscle from N-NH PET perfusion outperformed traditional myocardial viability parameters in predicting survival after CABG.SUVmean 比值的肝/肌肉和肺/肌肉从 N-NH 正电子发射断层扫描灌注术在预测 CABG 后生存率方面优于传统的心肌存活参数。
Jpn J Radiol. 2024 Nov;42(11):1270-1279. doi: 10.1007/s11604-024-01611-6. Epub 2024 Jun 10.